AAAAAA
Results: 26-50/187
Authors:
OLIVERIA SA
KLEIN RA
REED JI
CIRILLO PA
CHRISTOS PJ
WALKER AM
Citation: Sa. Oliveria et al., ESTROGEN REPLACEMENT THERAPY AND URINARY-TRACT INFECTIONS IN POSTMENOPAUSAL WOMEN AGED 45-89, Menopause, 5(1), 1998, pp. 4-8
Authors:
GENNARI C
AGNUSDEI D
CREPALDI G
ISAIA G
MAZZUOLI G
ORTOLANI S
BUFALINO L
PASSERI M
Citation: C. Gennari et al., EFFECT OF IPRIFLAVONE - A SYNTHETIC DERIVATIVE OF NATURAL ISOFLAVONES- ON BONE MASS-LOSS IN THE EARLY YEARS AFTER MENOPAUSE, Menopause, 5(1), 1998, pp. 9-15
Authors:
ARTEAGA E
ROJAS A
VILLASECA P
BIANCHI M
ARTEAGA A
DURAN D
Citation: E. Arteaga et al., IN-VITRO EFFECT OF ESTRADIOL, PROGESTERONE, TESTOSTERONE, AND OF COMBINED ESTRADIOL PROGESTINS ON LOW-DENSITY-LIPOPROTEIN (LDL) OXIDATION IN POSTMENOPAUSAL WOMEN/, Menopause, 5(1), 1998, pp. 16-23
Authors:
BUYUK E
GURLER A
ERENUS M
Citation: E. Buyuk et al., RELATIONSHIP BETWEEN CIRCULATING ESTRADIOL LEVELS, BODY-MASS INDEX, AND BREAKTHROUGH BLEEDING IN POSTMENOPAUSAL WOMEN RECEIVING HORMONE REPLACEMENT THERAPY, Menopause, 5(1), 1998, pp. 24-27
Authors:
CHEN YLD
VODA AM
MANSFIELD PK
Citation: Yld. Chen et al., CHINESE MIDLIFE WOMENS PERCEPTIONS AND ATTITUDES ABOUT MENOPAUSE, Menopause, 5(1), 1998, pp. 28-34
Authors:
MOTHERAL BR
FAIRMAN KA
Citation: Br. Motheral et Ka. Fairman, PATIENT EDUCATION-PROGRAMS AND CONTINUANCE WITH ESTROGEN REPLACEMENT THERAPY - EVALUATION OF THE WOMENS HEALTH EXCHANGE, Menopause, 5(1), 1998, pp. 35-42
Authors:
WILBUR J
MILLER AM
MONTGOMERY A
CHANDLER P
Citation: J. Wilbur et al., SOCIODEMOGRAPHIC CHARACTERISTICS, BIOLOGICAL FACTORS, AND SYMPTOM REPORTING IN MIDLIFE WOMEN, Menopause, 5(1), 1998, pp. 43-51
Authors:
WOODS NF
FALK S
SAVER B
TAYLOR GR
STEVENS N
MACLAREN A
Citation: Nf. Woods et al., DECIDING ABOUT HORMONE-THERAPY - VALIDATION OF A MODEL, Menopause, 5(1), 1998, pp. 52-59
Authors:
BRZEZINSKI A
Citation: A. Brzezinski, MELATONIN REPLACEMENT THERAPY FOR POSTMENOPAUSAL WOMEN - IS IT JUSTIFIED, Menopause, 5(1), 1998, pp. 60-64
Authors:
BOGGS PP
SCHIFF I
UTIAN WH
Citation: Pp. Boggs et al., ARCHER,DAVID,F., M.D. 1997-1998 NAMS PRESIDENT, Menopause, 4(4), 1997, pp. 189-190
Authors:
WILD R
Citation: R. Wild, THE IMPORTANCE OF LDL OXIDATION, Menopause, 4(4), 1997, pp. 191-192
Authors:
SAMSIOE G
ANDERSSON K
MATTSSON LA
Citation: G. Samsioe et al., RELATIVE FATTY-ACID COMPOSITION OF SERUM LECITHIN IN PERIMENOPAUSAL WOMEN USING COMBINED HORMONE REPLACEMENT THERAPY, Menopause, 4(4), 1997, pp. 193-196
Authors:
RODATRA A
MCKINNEY KA
PRICE J
MCFAUL P
Citation: A. Rodatra et al., EFFECT OF TAMOXIFEN ON SERUM ESTRADIOL CONCENTRATIONS AND THE DEVELOPMENT OF ENDOMETRIAL PATHOLOGY IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER, Menopause, 4(4), 1997, pp. 197-200
Authors:
FONSECA ME
CRUZ ML
LOUSTAUNAU E
OCHOA R
HERNANDEZ M
ZARATE A
Citation: Me. Fonseca et al., ESTROGEN REPLACEMENT THERAPY INCREASES PROLACTIN LEVELS IN POSTMENOPAUSAL WOMEN, Menopause, 4(4), 1997, pp. 201-205
Authors:
CAGNACCI A
VOLPE A
ARANGINO S
MALMUSI S
DRAETTA FP
MATTEO ML
MASCHIO E
VACCA AMB
MELIS GB
Citation: A. Cagnacci et al., DEPRESSION AND ANXIETY IN CLIMACTERIC WOMEN - ROLE OF HORMONE REPLACEMENT THERAPY, Menopause, 4(4), 1997, pp. 206-211
Authors:
SHAARAWY M
ELMALLAH SY
HASSAN HEE
AREF AI
Citation: M. Shaarawy et al., CHOICE OF RELIABLE BIOCHEMICAL MARKERS FOR ASSESSMENT OF BONE REMODELING IN POSTMENOPAUSAL OSTEOPOROSIS, Menopause, 4(4), 1997, pp. 212-218
Authors:
HOLT LH
TAFT LB
MOULTHROP JM
Citation: Lh. Holt et al., BONE-DENSITY MEASUREMENT - SURVEY OF USE AND IMPACT ON TREATMENT, Menopause, 4(4), 1997, pp. 219-224
Authors:
CASSON PR
HORNSBY PJ
GHUSN HF
BUSTER JE
Citation: Pr. Casson et al., DEHYDROEPIANDROSTERONE (DHEA) REPLACEMENT IN POSTMENOPAUSAL WOMEN - PRESENT STATUS AND FUTURE PROMISE, Menopause, 4(4), 1997, pp. 225-231
Citation: 8TH ANNUAL-MEETING OF THE NORTH-AMERICAN-MENOPAUSE-SOCIETY - ABSTRACT, Menopause, 4(4), 1997, pp. 235-288
Authors:
STAMPFER MJ
HANKINSON SE
Citation: Mj. Stampfer et Se. Hankinson, ESTROGEN AND BREAST-CANCER - THE DURATION CONNECTION, Menopause, 4(3), 1997, pp. 123-124
Authors:
ETTINGER B
QUESENBERRY C
SCHROEDER DA
FRIEDMAN G
Citation: B. Ettinger et al., LONG-TERM POSTMENOPAUSAL ESTROGEN THERAPY MAY BE ASSOCIATED WITH INCREASED RISK OF BREAST-CANCER - A COHORT STUDY, Menopause, 4(3), 1997, pp. 125-129
Authors:
TRABAL JF
LENIHAN JP
MELCHIONE TE
STOLTZ RR
KHAIRI S
YANG HM
VANDERHOOP RG
Citation: Jf. Trabal et al., LOW-DOSE UNOPPOSED ESTROGENS - PRELIMINARY FINDINGS ON THE FREQUENCY AND DURATION OF VAGINAL BLEEDING IN POSTMENOPAUSAL WOMEN RECEIVING ESTERIFIED ESTROGENS OVER A 2-YEAR PERIOD, Menopause, 4(3), 1997, pp. 130-138
Authors:
CASPER RF
DODIN S
REID RL
Citation: Rf. Casper et al., THE EFFECT OF 20 MU-G ETHINYL ESTRADIOL 1 MG NORETHINDRONE ACETATE (MINESTRIN(TM)), A LOW-DOSE ORAL-CONTRACEPTIVE, ON VAGINAL BLEEDING PATTERNS, HOT FLASHES, AND QUALITY-OF-LIFE IN SYMPTOMATIC PERIMENOPAUSAL WOMEN, Menopause, 4(3), 1997, pp. 139-147
Authors:
MCMANUS J
MCENENY J
LIGHTBODY J
THOMPSON W
YOUNG IS
Citation: J. Mcmanus et al., ESTROGENS INHIBIT COPPER AND NON-TRANSITION METAL-MEDIATED OXIDATION OF LOW-DENSITY-LIPOPROTEIN, Menopause, 4(3), 1997, pp. 148-153
Authors:
LEIDY LE
Citation: Le. Leidy, MENOPAUSAL SYMPTOMS AND EVERYDAY COMPLAINTS, Menopause, 4(3), 1997, pp. 154-160